糖尿病前期
医学
连续血糖监测
血糖性
糖尿病
逻辑回归
2型糖尿病
接收机工作特性
曲线下面积
升糖指数
2型糖尿病
内科学
内分泌学
作者
Simon Lebech Cichosz,Thomas Kronborg,Esben Laugesen,Stine Hangaard,Jesper Fleischer,Troels Krarup Hansen,Morten Hasselstrøm Jensen,Per Løgstrup Poulsen,Peter Vestergaard
标识
DOI:10.1089/dia.2024.0226
摘要
Objective: This study aims to investigate the continuum of glucose control from normoglycemia to dysglycemia (HbA1c ≥ 5.7% / 39 mmol/mol) using metrics derived from Continuous Glucose Monitoring (CGM). Additionally, we aim to develop a machine learning-based classification model to classify dysglycemia based on observed patterns. Methods: Data from five distinct studies, each featuring at least two days of CGM, were pooled. Participants included individuals classified as healthy, with prediabetes, or with type 2 diabetes mellitus (T2DM). Various CGM indices were extracted and compared across groups. The dataset was split 70/30 for training and testing two classification models (XGBoost / Logistic Regression) to differentiate between prediabetes or dysglycemia and the healthy group. Results: The analysis included 836 participants (healthy: n=282; prediabetes: n=133; T2DM: n=432). Across all CGM indices, a progressive shift was observed from the healthy group to those with diabetes (p<0.001). Statistically significant differences (p<0.01) were noted in mean glucose, Time Below Range, Time Above 140 mg/dl, Mmobility, Multiscale Complexity Index and Glycemic Risk Index when transitioning from health to prediabetes. The XGBoost models achieved the highest Receiver Operating Characteristic Area Under the Curve (ROC-AUC) values on the test dataset ranging from 0.91 [CI: 0.87-0.95] (prediabetes identification) to 0.97 [CI: 0.95-0.98] (Dysglycemia identification). Conclusion: Our findings demonstrate a gradual deterioration of glucose homeostasis and increased glycemic variability across the spectrum from normo- to dysglycemia, as evidenced by CGM metrics. The performance of CGM-based indices in classifying healthy individuals and those with prediabetes and diabetes is promising.
科研通智能强力驱动
Strongly Powered by AbleSci AI